Zoetis Inc’s filing revealed that its Director Reed Willie M acquired Company’s shares for reported $0.2 million on Mar 11 ’25. In the deal valued at $166.14 per share,1,210 shares were bought.
Then, Lagano Roxanne sold 326 shares, generating $55,420 in total proceeds. Upon selling the shares at $170.00, the Executive Vice President now owns 15,781 shares.
Before that, Reed Willie M sold 1,210 shares. Zoetis Inc shares valued at $201,029 were divested by the Director at a price of $166.14 per share. As a result of the transaction, Reed Willie M now holds 11,245 shares, worth roughly $1.85 million.
Leerink Partners initiated its Zoetis Inc [ZTS] rating to an Outperform in a research note published on December 02, 2024; the price target was $215. A number of analysts have revised their coverage, including BTIG Research’s analysts, who began to cover the stock in late July with a ‘”a Buy”‘ rating. Stifel also remained covering ZTS and reiterated its “Buy” recommendation on January 12, 2024.
Price Performance Review of ZTS
On Tuesday, Zoetis Inc [NYSE:ZTS] saw its stock fall -4.31% to $164.39. Over the last five days, the stock has lost -3.24%. Zoetis Inc shares have risen nearly 0.90% since the year began. Nevertheless, the stocks have fallen -9.43% over the past one year. While a 52-week high of $200.33 was reached on 02/06/25, a 52-week low of $144.80 was recorded on 02/18/25. SMA at 50 days reached $167.01, while 200 days put it at $177.08.
Levels Of Support And Resistance For ZTS Stock
The 24-hour chart illustrates a support level at 161.75, which if violated will result in even more drops to 159.11. On the upside, there is a resistance level at 169.42. A further resistance level may holdings at 174.46. The Relative Strength Index (RSI) on the 14-day chart is 45.66, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 2.41, which suggests price will go up in the next trading period. Percent R suggests that price movement has been low at 59.43%. Stochastics %K at 65.05% indicates the stock is a holding.
The most recent change occurred on December 07, 2023 when Exane BNP Paribas began covering the stock and recommended ‘”an Outperform”‘ rating along with a $237 price target.
